Eli Lilly And reported $81.2M in Interest Expense on Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Abbott ABT:US $ 106M 25M
ALKERMES ALKS:US 2.37M 19K
Amgen AMGN:US $ 328M 33M
Baxter International BAX:US $ 93M 5M
Biogen BIIB:US $ 65.8M 0.3M
Bristol Myers Squibb BMY:US $ 313M 13M
Catalent CTLT:US $ 32M 1M
Eli Lilly And LLY:US $ 81.2M 3.7M
Gilead Sciences GILD:US $ 242M 4M
Intercept Pharmaceuticals ICPT:US $ 6.67M 0M
JAZZ PHA JAZZ:US $ 63.89M 7M
Lannett LCI:US $ 14.81M 0.29M
Medtronic MDT:US $ 164M 21M
Neurocrine Biosciences NBIX:US $ 2.2M 0.4M
Novartis NOVN:VX 202M 1000K
Novartis NVS:US $ 202M 1M
Pfizer PFE:US $ 293M 29M
Prestige Brands PBH:US $ 15.29M 0.68M
Regeneron Pharmaceuticals REGN:US $ 13.1M 0.5M
Revance Therapeutics RVNC:US $ 3.87M 1.94M
Teva Pharmaceutical Industries TEVA:US $ 225M 13M
United Therapeutics UTHR:US $ 6.2M 1.5M
Zoetis ZTS:US $ 53M 0M